Reduced insular γ‐aminobutyric acid in fibromyalgia
Open Access
- 13 September 2011
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 64 (2), 579-583
- https://doi.org/10.1002/art.33339
Abstract
Objective Recent scientific findings have reinvigorated interest in examining the role of γ‐aminobutyric acid (GABA), the major inhibitory central nervous system neurotransmitter, in chronic pain conditions. Decreased inhibitory neurotransmission is a proposed mechanism in the pathophysiology of chronic pain syndromes such as fibromyalgia (FM). The purpose of this study was to test the hypothesis that decreased levels of insular and anterior cingulate GABA would be present in FM patients, and that the concentration of this neurotransmitter would be correlated with pressure–pain thresholds. Methods Sixteen FM patients and 17 age‐ and sex‐matched healthy controls underwent pressure–pain testing and a 3T proton magnetic resonance spectroscopy session in which the right anterior insula, right posterior insula, anterior cingulate, and occipital cortex were examined in subjects at rest. Results GABA levels in the right anterior insula were significantly lower in FM patients compared with healthy controls (mean ± SD 1.17 ± 0.24 arbitrary institutional units versus 1.42 ± 0.32 arbitrary institutional units; P = 0.016). There was a trend toward increased GABA levels in the anterior cingulate of FM patients compared with healthy controls (P = 0.06). No significant differences between groups were detected in the posterior insula or occipital cortex (P > 0.05 for all comparisons). Within the right posterior insula, higher levels of GABA were positively correlated with pressure–pain thresholds in the FM patients (Spearman's rho = 0.63; P = 0.02). Conclusion Diminished inhibitory neurotransmission resulting from lower concentrations of GABA within the right anterior insula may play a role in the pathophysiology of FM and other central pain syndromes.This publication has 16 references indexed in Scilit:
- Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled studyPain, 2011
- Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: A magnetic resonance spectroscopy studyArthritis & Rheumatism, 2010
- Elevated insular glutamate in fibromyalgia is associated with experimental painArthritis & Rheumatism, 2009
- Metabotropic receptors for glutamate and GABA in painBrain Research Reviews, 2009
- Polarity-Sensitive Modulation of Cortical Neurotransmitters by Transcranial StimulationJournal of Neuroscience, 2009
- Spatial effects in the detection of γ‐aminobutyric acid: Improved sensitivity at high fields using inner volume saturationMagnetic Resonance in Medicine, 2007
- How do we know that the pain in fibromyalgia is "real"?Current Pain and Headache Reports, 2006
- Differences in unpleasantness induced by experimental pressure pain between patients with fibromyalgia and healthy controlsEuropean journal of pain, 2005
- The effects of GABAB agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the ratPain, 2001
- Thermosensory activation of insular cortexNature Neuroscience, 2000